You have 9 free searches left this month | for more free features.

FTD

Showing 1 - 25 of 252

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

ALS, FTD Trial in Utrecht (WVE-004)

Enrolling by invitation
  • ALS
  • FTD
  • Utrecht, Netherlands
    Universitair Medisch Centrum Utrecht
Jan 4, 2023

Amyotrophic Lateral Sclerosis Trial in Jacksonville

Recruiting
  • Amyotrophic Lateral Sclerosis
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Nov 9, 2022

    Caregivers Burnout, Frontotemporal Dementia Trial in Portland (STELLA-FTD)

    Completed
    • Caregivers Burnout
    • Frontotemporal Dementia
    • STELLA-FTD
    • Portland, Oregon
      Oregon Health and Science University, Layton Aging and Alzheimer
    Apr 18, 2022

    Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

    Completed
    • Primary CNS Lymphoma (PCNSL)
    • HD-MTX-Ara-C regimen
    • FTD regimen
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Mar 2, 2022

    Frontotemporal Dementia Trial (LAM-002A)

    No longer available
    • Frontotemporal Dementia
    • (no location specified)
    Jul 29, 2022

    ALS, FTD Trial in Worldwide (WVE-004, Placebo)

    Active, not recruiting
    • ALS
    • FTD
    • North Ryde, New South Wales, Australia
    • +16 more
    Feb 2, 2023

    Amyotrophic Lateral Sclerosis, Frontotemporal Dementia Trial in Worldwide (TPN-101, 400 mg/day, Placebo)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Frontotemporal Dementia
    • TPN-101, 400 mg/day
    • Placebo
    • Orange, California
    • +4 more
    Mar 9, 2022

    Breast Cancer Trial in Singapore (Cohort A, Cohort B)

    Recruiting
    • Breast Cancer
    • Cohort A
    • Cohort B
    • Singapore, Singapore
      National University Hospital
    Apr 12, 2022

    Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Sep 24, 2023

    Frontotemporal Dementia Trial (ET-STEM)

    Not yet recruiting
    • Frontotemporal Dementia
    • (no location specified)
    May 11, 2022

    Alzheimer's Disease (AD), Lewy Body Dementia (LBD), Frontotemporal Degeneration (FTD) Trial in Paris (REALSOCOG, BCS,

    Not yet recruiting
    • Alzheimer's Disease (AD)
    • +2 more
    • REALSOCOG
    • +2 more
    • Paris, France
      Hôpital de la Pitié-Salpêtrière
    Oct 3, 2022

    Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)

    Terminated
    • Cholangiocarcinoma
    • Bile Duct Cancer
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Nov 28, 2022

    Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

    Not yet recruiting
    • PSP
    • +6 more
    • PAMSys
    • LEGSys
    • Baltimore, Maryland
    • +1 more
    Jul 20, 2023

    Voices Of Individuals: Challenges and Experiences Of bvFTD

    Enrolling by invitation
    • Frontotemporal Dementia
    • +3 more
    • Telephone Interview
    • Baltimore, Maryland
    • +2 more
    Jan 10, 2023

    Schizophrenia, Bipolar Disorder, Alzheimer Trial in Bron Cedex, Bron (blood sample taken)

    Recruiting
    • Schizophrenia
    • +3 more
    • blood sample taken
    • Bron Cedex, France
    • +1 more
    Oct 3, 2022

    Frontotemporal Dementia, Behavioral Variant Trial in Saint Paul (Novolin-R insulin)

    Suspended
    • Frontotemporal Dementia, Behavioral Variant
    • Novolin-R insulin
    • Saint Paul, Minnesota
      HealthPartners Neuroscience Center
    Nov 1, 2021

    Frontotemporal Dementia Trial in Boston, Roma (Transcranial Alternating Current Stimulation (tACS), Sham Transcranial

    Recruiting
    • Frontotemporal Dementia
    • Transcranial Alternating Current Stimulation (tACS)
    • Sham Transcranial Alternating Current Stimulation (sham tACS)
    • Boston, Massachusetts
    • +1 more
    Feb 2, 2022

    Frontotemporal Dementia (FTD) Trial in New York (Lithium Carbonate, Placebo)

    Recruiting
    • Frontotemporal Dementia (FTD)
    • Lithium Carbonate
    • Placebo
    • New York, New York
      Columbia University Medical Center
    Oct 7, 2021

    Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

    Active, not recruiting
    • Cholangiocarcinoma
    • +6 more
    • Laboratory Biomarker Analysis
    • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
    • Scottsdale, Arizona
    • +1 more
    Jan 4, 2023

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

      Completed
      • Metastatic Colorectal Cancer
      • Heraklion, Crete, Greece
      • +7 more
      Mar 4, 2022

      Human CNS Tau Kinetics in Tauopathies

      Completed
      • Progressive Supranuclear Palsy (PSP)
      • +2 more
      • 13C6 Leucine
      • Saint Louis, Missouri
        Washington University in St. Louis School of Medicine
      Apr 12, 2022

      Primary Progressive Aphasia, MCI, FTD Trial in Baltimore (Active HD-tDCS plus Speech-Language Therapy, Sham plus Speech-Language

      Recruiting
      • Primary Progressive Aphasia
      • +2 more
      • Active HD-tDCS plus Speech-Language Therapy
      • Sham plus Speech-Language Therapy
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Jun 21, 2022

      Neurodegenerative and Related Disorders

      Enrolling by invitation
      • PSP
      • +9 more
      • C-11 PiB
      • AV1451 Tau
      • Rochester, Minnesota
        Mayo Clinic
      Apr 7, 2022